Price $238.49 |
Market Cap
7.78B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
21.1
|
P/B
8.91
|
P/S
7.53
|
Dividend %
-
|
|
P/CF
159.3
|
P/FCF
40.4
|
Op. Cash Flow
238.4K
|
FCF
4.4
|
|
Op. Margin
46.60%
|
Net Margin
36.90%
|
ROE
56.50%
|
ROI
15.20%
|
|
ROA
36.20%
|
EPS Growth
371.70%
|
Current Ratio
1.8
|
Debt/Equity
0.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| PetIQ Inc (PETQ) | $34.99 | - | - | 1.06B | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $12.40 | - | - | 10.6B | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.73 | - | - | 19.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $4.65 | - | - | 166.4M | Strong Buy |
| Harrow Health Inc (HROW) | $8.65 | - | - | 159.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
